Primary Site >> Colorectal Cancer
Gene >> DEK
|
|
|
|
|
|---|---|---|---|---|
|
Ref: DEK Expression is controlled by E2F and deregulated in diverse tumor types. PMID: 16721057 |
Ref: FBXW7 influences murine intestinal homeostasis and cancer, targeting Notch, Jun, and DEK for degradation. PMID: 21282377 |
Ref: DEK over expression as an independent biomarker for poor prognosis in colorectal cancer. PMID: 23902796 |
Ref: Association of sedentary behavior with the expression levels of biomarkers in colorectal cancer: clinical analysis of 228 patients. PMID: 24621823 Ref: Mechanisms underlying cancer growth and apoptosis by DEK overexpression in colorectal cancer. PMID: 25340858 Ref: DEK is a potential marker for aggressive phenotype and irinotecan-based therapy response in metastatic colorectal cancer. PMID: 25515240 |
Ref: Epithelialmesenchymal transition in colorectal carcinoma cells is mediated by DEK/IMP3. PMID: 29115492 Ref: The potential predictive value of DEK expression for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer. PMID: 29409457 |